NICE confirms first-line SGLT-2 prescribing in final type 2 diabetes guidance

Final NICE type 2 diabetes guidance recommends offering SGLT-2 inhibitors much earlier.

GP Press Digest · Story from Pulse

NICE confirms first-line SGLT-2 prescribing in final type 2 diabetes guidance

Published 18 February 2026 · Prescribing & medicines

← GP Press Digest – week to 21 February 2026 · Story 2 of 3

PulseNews

In brief Final NICE type 2 diabetes guidance recommends offering SGLT-2 inhibitors much earlier.

Read the full article at Pulse ↗

Headline and link from Pulse (pulsetoday.co.uk); summary by BLMC. Pulse articles may need free registration. Inclusion isn't endorsement.

← Previous storyGP practices considering stopping flu vaccinations due to financial viabilityNext story →Global sum 'barely covers' staffing costs for GP practices, BMA data reveals
In this digest · GP Press Digest – week to 21 February 2026
  1. GP practices considering stopping flu vaccinations due to financial viability
  2. NICE confirms first-line SGLT-2 prescribing in final type 2 diabetes guidance
  3. Global sum 'barely covers' staffing costs for GP practices, BMA data reveals